Because the mouse anti-HM1.24 mAb exerted a marked anti-MM activity through the operation of ADCC and CDC machineries, we have established a humanized anti-HM1.24 mAb (AHM, IgG1-κ) by grafting the complementary-determining regions [52, 53]. The gene discussed is BST2; the disease is Miyoshi myopathy.